Dr. Khorvash determined computationally how an antibody specific towards Alzheimer's disease (AD) detects its toxic species, amyloid beta oligomers. The target regions were used to design a smaller version of the antibody and to predict the binding sites of oligomers on the surface of neurons, which can be used to design more effective antibodies.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Experimental Medicine (PhD) - graduated in 2020